Hcw Biologics Inc (HCWB) - News Archive

In the rapidly evolving field of immunotherapy, HCW Biologics Inc. has made significant strides with the presentation of groundbreaking preclinical data for its tetra-valent T-cell engager programme at the Society for I...

In a pivotal move within the landscape of immunotherapy, HCW Biologics has announced the designation of its proprietary TRBC-Pembrolizumab-based immune checkpoint inhibitor as its flagship therapeutic for internal clini...